{"product_id":"pigeon-herpesvirus-1-phv1-pigeon-herpesvirus-1-phv1-adenovirus-type-8-fadv-8-copy-copy","title":"Pigeon Paramyxovirus  type 1 (PMV1) - Pigeon Herpesvirus 1 (PHV1) - Adenovirus type 8 (FAdV-8)","description":"\u003ch3\u003ePharmavac PHA\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003ePharmavac PHA\u003c\/strong\u003e is an injectable emulsion designed specifically for pigeons.\u003c\/p\u003e\n\u003ch4\u003eComposition\u003c\/h4\u003e\n\u003cp\u003eEach vaccine dose (0.3 ml) contains:\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eActive Ingredients:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eInactivated Pigeon Paramyxovirus type 1 (PPMV1), strain 988M: ≥ 6.9 log2 HI*\u003c\/li\u003e\n\u003cli\u003eInactivated Pigeon Herpesvirus 1 (PHV1), strain V298\/70: ≥ 38.1 EU**\u003c\/li\u003e\n\u003cli\u003eInactivated Fowl Adenovirus type 8 (FAdV-8), strain M2\/E: ≥ 24.7 EU**\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e*Haemagglutination inhibition units in chicken.\u003cbr\u003e**ELISA units in chicken.\u003c\/p\u003e\n\u003ch4\u003eIndications\u003c\/h4\u003e\n\u003cp\u003e\u003cstrong\u003ePharmavac PHA\u003c\/strong\u003e is indicated for the active immunization of pigeons from 4 weeks of age to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eReduce mortality and decrease the frequency and severity of clinical signs associated with Paramyxovirus type 1 (PMV1).\u003c\/li\u003e\n\u003cli\u003eMitigate the severity of clinical signs, gross lesions, and virus shedding caused by Pigeon Herpesvirus (PHV1).\u003c\/li\u003e\n\u003cli\u003eAlleviate the severity of clinical signs and gross lesions associated with adenovirus (AdV), specifically types 7\/E, 2\/D, 3\/D, and 4\/C from subgroup I.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eOnset of Immunity\u003c\/strong\u003e: 3 weeks post-vaccination.\u003cbr\u003e\u003cstrong\u003eDuration of Immunity\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e12 months for the PMV1 component.\u003c\/li\u003e\n\u003cli\u003e5 months for the PHV1 and AdV components, supported by cell-mediated immunity and serological data.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eDosage and Administration\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage\u003c\/strong\u003e: 0.3 ml\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRoute\u003c\/strong\u003e: Administer one dose subcutaneously in the dorsal region of the neck, avoiding the head, starting at 4 weeks of age.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePreparation\u003c\/strong\u003e: Shake well before use and occasionally during administration. Allow the vaccine to reach room temperature before use.\u003c\/li\u003e\n\u003cli\u003eAdminister under standard aseptic conditions using sterile syringes and needles only. Use appropriately graduated syringes to ensure accurate dosing.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eVaccination Schedule\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePrimary Vaccination\u003c\/strong\u003e: 1 dose starting from 4 weeks of age.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRevaccination\u003c\/strong\u003e: Every 12 months for the PMV1 component, and every 5 months in breeding situations with PHV1 and AdV present.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eStorage Conditions\u003c\/h4\u003e\n\u003cp\u003eStore in a refrigerator at 2 °C – 8 °C. Protect from frost and light\u003c\/p\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":50209454391560,"sku":null,"price":176.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0876\/1429\/2232\/files\/PHA_RPVACC200dNewimage18-08-26_af6c6638-20cd-4116-9dbc-016948064195.jpg?v=1787094369","url":"https:\/\/racingpigeonlaboratorytesting.com\/nl\/products\/pigeon-herpesvirus-1-phv1-pigeon-herpesvirus-1-phv1-adenovirus-type-8-fadv-8-copy-copy","provider":"Racing Pigeon Laboratory Testing","version":"1.0","type":"link"}